Skip to main content

Nnamdi Gwacham, DO

Nnamdi Gwacham, DO

Physician

Cancer

Overview

Articles

Multidisciplinary approach to pelvic leiomyomatosis with intracaval and intracardiac extension: A case report and review of the literature

GYNECOLOGIC ONCOLOGY REPORTS

2022

MALIGNANT PERITONEAL CYTOLOGIC CONTAMINATION WITH ROBOTIC HYSTERECTOMY FOR ENDOMETRIAL CANCER

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

2022

Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives

GYNECOLOGIC ONCOLOGY

2021

Isolated vulvar Langerhans cell histiocytosis

GYNECOLOGIC ONCOLOGY REPORTS

2021

Plexiform Neurofibroma of the Uterus: A Case Report

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

2021

Improved Outcomes With an Enhanced Recovery Approach to Cesarean Delivery

OBSTETRICS AND GYNECOLOGY

2020

Leptomeningeal spread of gestational trophoblastic neoplasia in a 19-year old woman

GYNECOLOGIC ONCOLOGY REPORTS

2019

Associated Clinical Trials

NCT03517332

Association of ctDNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with advanced stage epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

Icon for trial | ctDNA Association of ctDNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with advanced stage epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

To compare the levels of ctDNA and CTCs using the SIGNATERA™ test in the peripheral blood of patients during neoadjuvant chemotherapy and after IDS for advanced stage epithelial ovarian carcinoma. Blood samples will be collecte ...